: Enzymotec and Nics Corporation signs on exclusive agreement
Food Ingredients First
Enzymotec Ltd., Israel has signed an exclusive agreement with Nics Corporation Ltd., Korea. According to this agreement, Nics will exclusively market InFat, to the dairy and infant formula markets in Korea. This is the second agreement for Enzymotec in the Korean market and part of its global effort to establish itself as a science driven producer of advanced bio-functional ingredients for the functional foods and nutraceuticals industries."